When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IPSEY - Galderma advancing ready-to-use botulinum toxin for frown lines
Ipsen SA ADR
Nestle S.A. (OTCPK:NSRGY) subsidiary Galderma announces positive results from a Phase 2 clinical trial evaluating QM1114, its ready-to-use liquid formulation of botulinum toxin type A, for the treatment of glabellar lines (frown lines).
More news on: Nestlé S.A., Allergan plc, Evolus, Inc., Healthcare stocks news, Consumer stocks news,